⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLNO News
Soleno Therapeutics, Inc. Common Stock
SLNO INVESTOR ALERT: Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman
prnewswire.com
SLNO
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
SLNO
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
globenewswire.com
SLNO
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
SLNO
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
prnewswire.com
SLNO
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SLNO
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
accessnewswire.com
SLNO
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLNO
accessnewswire.com
SLNO
SLNO INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Soleno Therapeutics, Inc. Investors
accessnewswire.com
SLNO
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
globenewswire.com
SLNO